Clinical Trials · NCT07508020

A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity

Phase
Phase 1
Recruitment status
Recruiting
Sponsor
Novo Nordisk A/S
Enrollment
120
Start date
Mar 2026
Locations
1 site, Germany
Primary endpoint
Relative change from baseline in total energy intake across ad libitum breakfast, lunch, evening meal and snack box to Day 126
View Amycretin compound reference